Alcashell Eye Drop: Alcaftadine - Fast Relief for Ocular Itching

Dual Mechanism: Antihistamine and Mast Cell Stabilizer Action

Key Indications: Effective Treatment for Seasonal and Perennial Allergic Conjunctivitis

Dosage Advantage: Convenient Once-Daily Dosing for Patient Compliance

Administration and Safety: Clear Instructions for Treating Eye Allergies
Exclusive Opportunity: Alcashell Eye Drop PCD Pharma Franchise in Ophthalmology

Home/Products /alcaftadine-2-5mg-ml-eye-drop

Caftashell Eye Drops

Composition : Alcaftadine (2.5mg/ml) Eye Drop

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹1/-

Alcashell Eye Drop contains Alcaftadine 2.5 mg/ml, a highly effective ophthalmic solution specifically developed to treat and prevent ocular itching associated with allergic conjunctivitis. This condition, commonly known as eye allergy, is a widespread complaint, making Alcashell a high-demand product.

Mechanism and Impact:Alcaftadine offers a powerful dual mechanism of action. First, it acts as a highly selective H1-receptor antagonist (antihistamine), blocking the histamine that causes immediate eye itching. Second, it stabilizes mast cells, preventing them from releasing more inflammatory mediators. This combined action not only provides fast relief but also offers long-lasting protection, often allowing for a convenient once-daily dosing schedule.

Key Therapeutic Uses:

  • Ocular Itching Relief: Rapidly reduces the primary symptom of eye allergies.

  • Allergic Conjunctivitis: Effective for managing both seasonal and year-round allergic reactions.

We offer an exclusive PCD Pharma Franchise opportunity for Alcashell Eye Drop, ensuring partners can capitalize on the consistent market requirement for superior eye allergy treatments.

Read More

About the Product

Alcashell Eye Drop contains Alcaftadine 2.5 mg/ml, a highly effective ophthalmic solution specifically developed to treat and prevent ocular itching associated with allergic conjunctivitis. This condition, commonly known as eye allergy, is a widespread complaint, making Alcashell a high-demand product.

Mechanism and Impact:Alcaftadine offers a powerful dual mechanism of action. First, it acts as a highly selective H1-receptor antagonist (antihistamine), blocking the histamine that causes immediate eye itching. Second, it stabilizes mast cells, preventing them from releasing more inflammatory mediators. This combined action not only provides fast relief but also offers long-lasting protection, often allowing for a convenient once-daily dosing schedule.

Key Therapeutic Uses:

  • Ocular Itching Relief: Rapidly reduces the primary symptom of eye allergies.

  • Allergic Conjunctivitis: Effective for managing both seasonal and year-round allergic reactions.

We offer an exclusive PCD Pharma Franchise opportunity for Alcashell Eye Drop, ensuring partners can capitalize on the consistent market requirement for superior eye allergy treatments.

Common, mild side effects may include brief eye irritation, slight discomfort, or a temporary burning sensation upon application.

Moxolunic BF Eye Drop (BAK Free) Indicated for treating bacterial eye infections, reducing post-surgical pain, redness, and swelling, and alleviating associated itching and discomfort.

Information regarding the use of Moxolunic BF Eye Drop (BAK Free) during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place at room temperature (15°C to 25°C). Keep the bottle tightly closed and away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation